Source: 5 News Online

VAN BUREN, Ark. — A local man says he took the drug hydroxychloroquine while he had COVID-19 and within a few days felt better.

He did this despite warnings from the majority of medical organizations such as the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health warning against it.

Steve Allen of Van Buren was diagnosed with COVID-19 at the end of July.

“I just felt like it was getting a sinus infection,” Allen said.

Allen says after his doctor refused to prescribe him anything he got a prescription for hydroxychloroquine, zinc and vitamin D-3 from a physician’s assistant that he knew.

“After the first couple of doses I could really tell it was breaking up the chest congestion, and I was coughing a lot and ended up going to the ER because I was having a hard time breathing,” Allen said.

Allen claims the ER doctor told him to continue taking hydroxychloroquine, along with steroids and within a matter of days, he felt much better.

“I’m not saying it would do that for everyone, but I think it’s pretty crazy that we can’t have a conversation with our doctor about a medication that may work,” Allen said.

Panamanian Specialist physicians: There is no risk in the use of hydroxychloroquine in stable patients.

Big Tech Silencing Physicians: A Very Dangerous Road for American Medicine

Brazil: After hydroxychloroquine use, ICU bed occupancy drops from 100% to 30% in Sertãozinho

China Study of 2882 patients: Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs

Italian Study: Hydroxychloroquine Cut Death Risk 66 Percent

Houston-area doctor agrees with use of controversial drug to treat COVID-19

Yale’s Dean of Public Health defends right to argue hydroxychloroquine could save lives

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »